Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome - Related Studies

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome

This study has been completed.

Study NCT00004776. Last updated on June 23, 2005. Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Lennox-Gastaut Syndrome

2	Additional conditions recognized in this trial
		Syndrome

3	More general conditions related to this trial
		Disease
		Pathologic Processes

4	Interventions listed in this trial
		topiramate

5	More general drug interventions related to this trial
		Anti-Obesity Agents
		Anticonvulsants
		Central Nervous System Agents
		Neuroprotective Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Center for Research Resources (NCRR)
		University of California, Los Angeles